(283 days)
Not Found
No
The description focuses on standard Doppler ultrasound technology for measuring fetal heart rate and outputting sound, with no mention of AI or ML algorithms for analysis, prediction, or interpretation beyond basic heart rate calculation.
No
The device is strictly for monitoring fetal heart rate and well-being, which is a diagnostic function, not a therapeutic intervention. It does not treat or alleviate a medical condition.
Yes
Explanation: The device measures fetal heart rate to "predict fetal well-being," which is a diagnostic purpose to assess the health of the fetus.
No
The device description explicitly states it is a "pocket sized ultrasonic fetal monitor" and a "pocket size Fetal Doppler" that "irradiates ultrasound wave" and has a "built-in speaker" and "LCD display," indicating it is a hardware device with integrated software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to examine these samples outside of the body.
- Device Function: The BT-220L/220C is a fetal monitor that uses Doppler ultrasound to measure the fetal heart rate directly on the pregnant woman's abdomen. It does not analyze samples taken from the body.
- Intended Use: The intended use is to measure fetal heart rate and output fetal heart sounds, which is a direct measurement on the patient, not an analysis of a biological sample.
Therefore, based on the provided information, the BT-220L/220C is a medical device, but it falls under the category of a non-IVD device.
N/A
Intended Use / Indications for Use
BT-220L/220C is a pocket sized ultrasonic fetal monitor that measures heart rate, which is displayed on an LCD display, and outputs fetal heart sounds through a built in speaker.
The fetal heart rate is measured using Doppler ultrasound.
Product codes (comma separated list FDA assigned to the subject device)
HGM
Device Description
Bistos' BT-220L, BT-220C is a pocket size Fetal Doppler that measures the fetal heart rate and out put the fetal sound through built-in speaker. By measuring fetal heart rate (FHR), they are able to predict fetal well-being. BT-220 irradiates ultrasound wave to the abdomen of a pregnant women to detect. The Doppler frequency signal and analyze, displays the heart rate in LCD screen. The device also provides the heart sound from the heart of fetus.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Doppler Ultrasound
Anatomical Site
abdomen of a pregnant women
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
- HR Accuracy Measuring Report
- Acoustic Output Test Report
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 884.2740 Perinatal monitoring system and accessories.
(a)
Identification. A perinatal monitoring system is a device used to show graphically the relationship between maternal labor and the fetal heart rate by means of combining and coordinating uterine contraction and fetal heart monitors with appropriate displays of the well-being of the fetus during pregnancy, labor, and delivery. This generic type of device may include any of the devices subject to §§ 884.2600, 884.2640, 884.2660, 884.2675, 884.2700, and 884.2720. This generic type of device may include the following accessories: Central monitoring system and remote repeaters, signal analysis and display equipment, patient and equipment supports, and component parts.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the symbol. The logo is simple and recognizable, representing the department's role in promoting the health and well-being of Americans.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 9, 2015
Bistos Co., Ltd % Young Chi President Bio-Med USA Inc. 27 New England Drive Ramsey, New Jersey 07446
Re: K142799
Trade/Device Name: Model BT-220L and BT-220C Regulation Number: 21 CFR 884.2740 Regulation Name: Perinatal monitoring system and accessories Regulatory Class: Class II Product Code: HGM Dated: June 2, 2015 Received: June 9, 2015
Dear Young Chi,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Benjamin R. Fisher -S
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K142799
Device Name Ultrasonic Fetal Doppler Model BT-220L and BT-220C
Indications for Use (Describe)
BT-220L/220C is a pocket sized ultrasonic fetal monitor that measures heart rate, which is displayed on an LCD display, and outputs fetal heart sounds through a built in speaker.
The fetal heart rate is measured using Doppler ultrasound.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) Summary
As required by CFR 807.92(c)
1. Manufacturer
Prepared July 1, 2015
Bistos Co., Ltd. Reg Nr:3006179052 7th fl, A bldg WooLim Lions 3-cha 302 Galmachi ro, JungWon gu, Seoung Nam, GyungGi do, Rep of Korea Tel: 82 2 2108 4626 Fax : 82 2 2108 4629
2. Submitter, Contact person
Mr. Young Chi / President BioMed USA Inc. 27 New England Drive, Ramsey, NJ 07505. U.S.A. Tel: 973 278 5222 Fax: 201 934 6030 E mail: biomedusa@msn.com
3. Name of Device
| Trade name : | Model BT-220L and BT-2200 |
|---|---|
| Common or usual name : | Ultrasonic Fetal Doppler |
| Regulation number : | 884.2660 |
| Regulation class : | II |
| Product code : | HGM |
| Classification panel : | Obstetrics / Gynecology |
4. Substantial Equivalence.
Bistos BT-220 Ultrasonic Fetal monitor is substantially equivalent in Intended use, Design, Function, Performance and all used material, direction to use, software, producing process, technology/principle of operation to already cleared BT-200T under 510(K)100885.
5. Indication for use.
The 220L/220C is a pocket sized ultrasonic fetal monitor that measures heart rate, which is displayed on an LCD display, and outputs fetal heart sounds through a built in speaker. the fetal heart rate is measured using Doppler Ultrasound.
4
6. Device Description
Bistos' BT-220L, BT-220C is a pocket size Fetal Doppler that measures the fetal heart rate and out put the fetal sound through built-in speaker. By measuring fetal heart rate (FHR), they are able to predict fetal well-being. BT-220 irradiates ultrasound wave to the abdomen of a pregnant women to detect. The Doppler frequency signal and analyze, displays the heart rate in LCD screen. The device also provides the heart sound from the heart of fetus.
Operating mode
- Continuous Pulsed Doppler ●
- . Fetal Movement
Detail, Engineering design. Performing features, Operating mode, attached
7. Biocompatibility test.
All used material of patient contacted part was done Biocompatibility test by NAMSA ( North American Science ) by FDA guidance Blue Book Memo G95-1 use of ISO 10993 Biological Evaluation of Medical Device part 4, 5, 10.
Body contacting classification: Surface device, skin, limited less than 24 hrs. The Skin contacting materials were found to be biocompatible.
Attached the Biocompatibility Certificate. (F)
8. Voluntary performed safety test result attached (B-E)
-
- HR Accuracy Measuring Report (G)
-
- Acoustic Output Test Report (F)
-
- CB Test Certificate (B, E)
9.Conclusion
Bistos' BT-220L/C Pocket size Fetal monitor in this submission is substantially equivalent to the already cleared BT-200T under K100885 at design, specification, intended use, used material, direction to use, software, Technology/principal operating and Performing etc in every angles.